The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification - Shi, Chaoji; Ju, Houyu; Zhou, Rong; Xu, Shengming; Wu, Yunteng; Gu, Ziyue; Wang, Ying; Chen, Wanling; Huang, Xinyi; Han, Yong; Sun, Shuyang; Li, Chuwen; et al. (BMC Medicine, 2024)